Cite
HARVARD Citation
Alex, P. et al. (2020). Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study. Clinical and experimental dermatology. pp. 318-322. [Online].